Novo Nordisk Inc. issues voluntary nationwide recall of six batches of GlucaGen ® HypoKit® (glucagon [rDNA origin] for injection) due to detached needles on the syringe in the kit

Novo Nordisk Inc. is recalling six batches of the GlucaGen ® HypoKit® in the U.S. due to two customer complaints from the UK and Portugal involving detached needles on the syringe with Sterile Water for Injection (SWFI). GlucaGen® HypoKit® is indicated for the treatment of severe hypoglycemia (low blood sugar) in patients with diabetes who are treated w ith insulin. A syringe with a detached needle cannot be used as prescribed.
Source: Food and Drug Administration - Category: Food Science Source Type: news